» Articles » PMID: 29020085

Success Rates in Smoking Cessation: Psychological Preparation Plays a Critical Role and Interacts with Other Factors Such As Psychoactive Substances

Overview
Journal PLoS One
Date 2017 Oct 12
PMID 29020085
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The aim of this study was to identify factors associated with the results of smoking cessation attempts.

Methods: Data were collected in Clermont-Ferrand from a smoking cessation clinic between 1999 and 2009 (1,361 patients). Smoking cessation was considered a success when patients were abstinent 6 months after the beginning of cessation. Multivariate logistic regression was used to investigate the association between abstinence and different factors.

Results: The significant factors were a history of depression (ORadjusted = 0.57, p = 0.003), state of depression at the initial consultation (ORa = 0.64, p = 0.005), other psychoactive substances (ORa = 0.52, p<0.0001), heart, lung and Ear-Nose-Throat diseases (ORa = 0.65, p = 0.005), age (ORa = 1.04, p<0.0001), the Richmond test (p<0.0001; when the patient's motivation went from insufficient to moderate, the frequency of abstinence was twice as high) and the Prochaska algorithm (p<0.0001; when the patient went from the 'pre-contemplation' to the 'contemplation' level, the frequency of success was four times higher). A high score in the Richmond test had a greater impact on success with increasing age (significant interaction: p = 0.01). In exclusive smokers, the contemplation level in the Prochaska algorithm was enough to obtain a satisfactory abstinence rate (65.5%) whereas among consumers of other psychoactive substances, it was necessary to reach the preparation level in the Prochaska algorithm to achieve a success rate greater than 50% (significant interaction: p = 0.02).

Conclusion: The psychological preparation of the smoker plays a critical role. The management of smoking cessation must be personalized, especially for consumers of other psychoactive substances and/or smokers with a history of depression.

Citing Articles

Feasibility of a Stop Smoking Program for Healthcare Workers in an Italian Hospital: Econometric Analysis in a Total Worker Health® Approach.

Di Prinzio R, Bondanini G, De Falco F, Vinci M, Camisa V, Santoro A Ann Glob Health. 2023; 89(1):56.

PMID: 37663224 PMC: 10473173. DOI: 10.5334/aogh.4153.


Effectiveness of a Smoking Cessation Program during the COVID-19 Pandemic.

Kruk A, Czerwinska C, Dolna-Michno J, Broniatowska E, Kolanko E Healthcare (Basel). 2023; 11(11).

PMID: 37297676 PMC: 10252602. DOI: 10.3390/healthcare11111536.


Prevalence and predictors of smoking cessation among smokers receiving smoking cessation intervention in primary care in Qatar: a 6-month follow-up study.

Al-Dahshan A, Al Muraikhi H, Musa S, Joudeh A, Al Baker W, Selim N Front Public Health. 2023; 11:1166016.

PMID: 37275499 PMC: 10235512. DOI: 10.3389/fpubh.2023.1166016.


Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia.

Choo S, Chang C, Tangiisuran B, Latif M, Sanusi N, Harun S Int J Environ Res Public Health. 2022; 19(13).

PMID: 35805417 PMC: 9265789. DOI: 10.3390/ijerph19137757.


Smoking Cessation at the Community Pharmacy: Determinants of Success from a Real-Life Practice.

Condinho M, Ramalhinho I, Sinogas C Pharmacy (Basel). 2021; 9(3).

PMID: 34449711 PMC: 8396305. DOI: 10.3390/pharmacy9030143.


References
1.
Karam-Hage M, Cinciripini P, Gritz E . Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014; 64(4):272-90. PMC: 4377321. DOI: 10.3322/caac.21231. View

2.
Dautzenberg B . [Methods and results of smoking cessation in cancer smoker's]. Bull Cancer. 2012; 99(11):1007-15. DOI: 10.1684/bdc.2012.1656. View

3.
Taylor G, McNeill A, Aveyard P . Does deterioration in mental health after smoking cessation predict relapse to smoking?. BMC Public Health. 2015; 15:1150. PMC: 4654809. DOI: 10.1186/s12889-015-2473-z. View

4.
Hartmann-Boyce J, Stead L, Cahill K, Lancaster T . Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction. 2014; 109(9):1414-25. DOI: 10.1111/add.12633. View

5.
Codern-Bove N, Pujol-Ribera E, Pla M, Gonzalez-Bonilla J, Granollers S, Ballve J . Motivational interviewing interactions and the primary health care challenges presented by smokers with low motivation to stop smoking: a conversation analysis. BMC Public Health. 2014; 14:1225. PMC: 4289187. DOI: 10.1186/1471-2458-14-1225. View